Metropolitan Life Insurance Company (MetLife)’s Everest Group EG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,751
| Closed | -$696K | – | 651 |
|
|
2024
Q1 | $696K | Sell |
1,751
-16
| -0.9% | -$6K | 0.03% | 413 |
|
|
2023
Q4 | $625K | Sell |
1,767
-30
| -2% | -$11.6K | 0.03% | 423 |
|
|
2023
Q3 | $668K | Sell |
1,797
-72
| -4% | -$26.1K | 0.03% | 384 |
|
|
2023
Q2 | $639K | Buy |
1,869
+116
| +7% | +$41.9K | 0.03% | 413 |
|
|
2023
Q1 | $628K | Sell |
1,753
-460
| -21% | -$165K | 0.03% | 419 |
|
|
2022
Q4 | $733K | Sell |
2,213
-134
| -6% | -$41.7K | 0.03% | 431 |
|
|
2022
Q3 | $616K | Sell |
2,347
-29
| -1% | -$7.85K | 0.03% | 448 |
|
|
2022
Q2 | $666K | Sell |
2,376
-54
| -2% | -$15.3K | 0.03% | 455 |
|
|
2022
Q1 | $732K | Sell |
2,430
-2,471
| -50% | -$710K | 0.03% | 482 |
|
|
2021
Q4 | $1.34M | Sell |
4,901
-208
| -4% | -$56.2K | 0.02% | 757 |
|
|
2021
Q3 | $1.28M | Sell |
5,109
-194
| -4% | -$49.8K | 0.02% | 788 |
|
|
2021
Q2 | $1.34M | Buy |
5,303
+375
| +8% | +$97.6K | 0.02% | 788 |
|
|
2021
Q1 | $1.22M | Sell |
4,928
-241
| -5% | -$57.4K | 0.02% | 807 |
|
|
2020
Q4 | $1.21M | Sell |
5,169
-276
| -5% | -$60.9K | 0.02% | 761 |
|
|
2020
Q3 | $1.08M | Sell |
5,445
-256
| -4% | -$54.8K | 0.02% | 698 |
|
|
2020
Q2 | $1.18M | Sell |
5,701
-1,016
| -15% | -$198K | 0.02% | 640 |
|
|
2020
Q1 | $1.29M | Sell |
6,717
-51
| -0.8% | -$13K | 0.03% | 561 |
|
|
2019
Q4 | $1.87M | Buy |
6,768
+3
| +0% | +$791 | 0.03% | 576 |
|
|
2019
Q3 | $1.8M | Sell |
6,765
-172
| -2% | -$43.4K | 0.03% | 556 |
|
|
2019
Q2 | $1.71M | Buy |
6,937
+368
| +6% | +$88.3K | 0.03% | 596 |
|
|
2019
Q1 | $1.42M | Sell |
6,569
-171
| -3% | -$37.2K | 0.03% | 681 |
|
|
2018
Q4 | $1.47M | Sell |
6,740
-55
| -0.8% | -$12K | 0.03% | 592 |
|
|
2018
Q3 | $1.55M | Sell |
6,795
-223
| -3% | -$49.9K | 0.03% | 669 |
|
|
2018
Q2 | $1.62M | Buy |
7,018
+660
| +10% | +$155K | 0.03% | 643 |
|
|
2018
Q1 | $1.63M | Buy |
6,358
+10
| +0.2% | +$2.4K | 0.02% | 661 |
|
|
2017
Q4 | $1.41M | Sell |
6,348
-13,140
| -67% | -$2.96M | 0.02% | 740 |
|
|
2017
Q3 | $4.45M | Sell |
19,488
-415
| -2% | -$105K | 0.03% | 647 |
|
|
2017
Q2 | $5.07M | Sell |
19,903
-18,234
| -48% | -$4.5M | 0.04% | 566 |
|
|
2017
Q1 | $8.92M | Sell |
38,137
-85
| -0.2% | -$19.4K | 0.06% | 296 |
|
|
2016
Q4 | $8.27M | Sell |
38,222
-1,069
| -3% | -$220K | 0.06% | 307 |
|
|
2016
Q3 | $7.46M | Sell |
39,291
-469
| -1% | -$88.2K | 0.05% | 332 |
|
|
2016
Q2 | $7.26M | Buy |
+39,760
| New | +$7.31M | 0.05% | 341 |
|
|
2014
Q3 | – | Sell |
-38,604
| Closed | -$6.15M | – | 2682 |
|
|
2014
Q2 | $6.15M | Sell |
38,604
-958
| -2% | -$152K | 0.04% | 440 |
|
|
2014
Q1 | $6.05M | Buy |
39,562
+258
| +0.7% | +$38.1K | 0.04% | 445 |
|
|
2013
Q4 | $6.13M | Sell |
39,304
-409
| -1% | -$62.5K | 0.04% | 433 |
|
|
2013
Q3 | $5.78M | Sell |
39,713
-510
| -1% | -$69.1K | 0.04% | 428 |
|
|
2013
Q2 | $5.16M | Buy |
+40,223
| New | +$5.2M | 0.04% | 436 |
|
Other funds holding EG
CIP
Metropolitan Life Insurance Company (MetLife)'s EG Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Everest Group (EG) in Q2 2024, closing a stake of 1,751 shares — an estimated $696K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in EG in Q2 2013 and held it in 37 quarters. The position peaked at $8.92M in Q1 2017. 631 funds tracked by Wall St. Rank hold EG as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Everest Group position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,751 Everest Group shares in Q2 2024, an estimated $696K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Everest Group in Q2 2013 and held it in 37 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Everest Group position peaked at $8.92M in Q1 2017.
- 631 funds tracked by Wall St. Rank held Everest Group as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.